Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
5 clinical trials · Sponsor
◉ Watch Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
| Record | Firm | Date |
|---|---|---|
| Subcutaneous Infliximab After A Previous Intravenous Dose Optimization (NCT06113913) | Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW | 2024-04-09 |
| ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA (NCT05992142) | Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW | 2023-01-17 |
| An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients with Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study (NCT05299931) | Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW | 2021-09-10 |
| Loss of RESponse to Ustekinumab Treated by Dose Escalation (NCT04245215) | Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW | 2020-03-11 |
Track Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW automatically
Every clearance here is in the API, with alerts when new ones post.